Literature DB >> 16754783

Organic cation/carnitine transporter OCTN2 (Slc22a5) is responsible for carnitine transport across apical membranes of small intestinal epithelial cells in mouse.

Yukio Kato1, Mikihiro Sugiura, Tomoko Sugiura, Tomohiko Wakayama, Yoshiyuki Kubo, Daisuke Kobayashi, Yoshimichi Sai, Ikumi Tamai, Shoichi Iseki, Akira Tsuji.   

Abstract

The organic cation/carnitine transporter OCTN2 is responsible for renal tubular reabsorption of its endogenous substrate, carnitine, although its physiological role in small intestine remains controversial. Here we present direct evidence for a predominant role of OCTN2 in small intestinal absorption of carnitine based on experiments with juvenile visceral steatosis (jvs) mice, which have a hereditary deficiency of the octn2 gene. Uptake of carnitine, assessed with an Ussing-type chamber system, from the apical surface of the small intestine was saturable and higher than that from the basal surface in wild-type mice, whereas carnitine uptake having these characteristics was almost absent in jvs mice. Saturable uptake of carnitine was also confirmed in isolated enterocytes obtained from wild-type mice, and the Km value obtained (approximately 20 microM) was close to that reported for carnitine uptake by human embryonic kidney 293 cells stably expressing mouse OCTN2 (Slc22a5). The carnitine uptake by enterocytes was decreased in the presence of various types of organic cations, and this inhibition profile was similar to that of mouse OCTN2, whereas uptake of carnitine was quite small and unsaturable in enterocytes obtained from jvs mice. Immunohistochemical and immunoprecipitation analyses suggested colocalization of OCTN2 with PDZK1, an adaptor protein that functionally regulates OCTN2. Immunoelectron microscopy visualized both OCTN2 and PDZK1 in microvilli of absorptive epithelial cells. These findings indicate that OCTN2 is predominantly responsible for the uptake of carnitine from the apical surface of mouse small intestinal epithelial cells, and it may therefore be a promising target for oral delivery of therapeutic agents that are OCTN2 substrates.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16754783     DOI: 10.1124/mol.106.024158

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  20 in total

1.  Enzymes involved in L-carnitine biosynthesis are expressed by small intestinal enterocytes in mice: implications for gut health.

Authors:  Prem S Shekhawat; Srinivas Sonne; A Lee Carter; Dietrich Matern; Vadivel Ganapathy
Journal:  J Crohns Colitis       Date:  2012-09-21       Impact factor: 9.071

Review 2.  Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects.

Authors:  Stephanie E Reuter; Allan M Evans
Journal:  Clin Pharmacokinet       Date:  2012-09-01       Impact factor: 6.447

3.  Inhibition of OCTN2-mediated transport of carnitine by etoposide.

Authors:  Chaoxin Hu; Cynthia S Lancaster; Zhili Zuo; Shuiying Hu; Zhaoyuan Chen; Jeffrey E Rubnitz; Sharyn D Baker; Alex Sparreboom
Journal:  Mol Cancer Ther       Date:  2012-03-02       Impact factor: 6.261

4.  Quantitative structure activity relationship for inhibition of human organic cation/carnitine transporter.

Authors:  Lei Diao; Sean Ekins; James E Polli
Journal:  Mol Pharm       Date:  2010-09-29       Impact factor: 4.939

Review 5.  Genetic update on inflammatory factors in ulcerative colitis: Review of the current literature.

Authors:  Patricia Sarlos; Erzsebet Kovesdi; Lili Magyari; Zsolt Banfai; Andras Szabo; Andras Javorhazy; Bela Melegh
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

Review 6.  Remote communication through solute carriers and ATP binding cassette drug transporter pathways: an update on the remote sensing and signaling hypothesis.

Authors:  Wei Wu; Ankur V Dnyanmote; Sanjay K Nigam
Journal:  Mol Pharmacol       Date:  2011-02-11       Impact factor: 4.436

7.  Uptake of pramipexole by human organic cation transporters.

Authors:  Lei Diao; Yan Shu; James E Polli
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

8.  NHERF3 (PDZK1) contributes to basal and calcium inhibition of NHE3 activity in Caco-2BBe cells.

Authors:  Nicholas C Zachos; Xuhang Li; Olga Kovbasnjuk; Boris Hogema; Rafiquel Sarker; Luke J Lee; Min Li; Hugo de Jonge; Mark Donowitz
Journal:  J Biol Chem       Date:  2009-06-17       Impact factor: 5.157

9.  Transport of butyryl-L-carnitine, a potential prodrug, via the carnitine transporter OCTN2 and the amino acid transporter ATB(0,+).

Authors:  Sonne R Srinivas; Puttur D Prasad; Nagavedi S Umapathy; Vadivel Ganapathy; Prem S Shekhawat
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-09-13       Impact factor: 4.052

Review 10.  Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

Authors:  Curtis D Klaassen; Lauren M Aleksunes
Journal:  Pharmacol Rev       Date:  2010-01-26       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.